FDA warning signs consultant when GH is authorised; off-label use requires stable facts, cautious tracking

https://www.pexels.com/@julia-pritchard-2160782411/

FDA signs manual while GH is accredited; off-label use calls for robust proof, cautious monitoring, and clear consent discussions.